Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China flag China · Delayed Price · Currency is CNY
74.59
-2.55 (-3.31%)
At close: May 29, 2026

SHE:301075 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
65.4485.28262.13405.27425.76610.93
Trading Asset Securities
-20.04141.6877.5780-
Cash & Short-Term Investments
65.44105.32403.81482.84505.76610.93
Cash Growth
-83.79%-73.92%-16.37%-4.53%-17.21%484.67%
Accounts Receivable
108.487.89107.9485.5192.3100.33
Other Receivables
20.6517.0919.5511.27.882.28
Receivables
129.05104.98127.4996.7100.18102.6
Inventory
99.9883.5445.8533.1332.779.82
Prepaid Expenses
--00.050.060.06
Other Current Assets
35.0735.2353.6136.238.665.64
Total Current Assets
329.54329.06630.75648.95647.43729.05
Property, Plant & Equipment
721.58694.53652.8209.8110.68103.41
Long-Term Investments
110.62110.99108.18155.36112.62-
Goodwill
18.718.719.223.69--
Other Intangible Assets
74.5176.6478.4834.1921.2416.85
Long-Term Deferred Tax Assets
3.443.493.091.250.780.65
Long-Term Deferred Charges
1.922.012.842.70.331.46
Other Long-Term Assets
67.3447.839.6416.335.8-
Total Assets
1,3281,2831,5351,072898.87851.42
Accounts Payable
97.4677.2958.1426.7712.1323.01
Accrued Expenses
3.997.2598.5813.0910.46
Short-Term Debt
57.7767.76275.5450.13100.0620
Current Portion of Long-Term Debt
109.36110.36115.2111.01--
Current Portion of Leases
--3.030.60.290.48
Current Income Taxes Payable
1.150.391.262.411.352.87
Current Unearned Revenue
7.827.552.785.084.163.72
Other Current Liabilities
173.57171.5544.4124.613.492.25
Total Current Liabilities
451.12442.14509.37129.18144.5762.79
Long-Term Debt
88.588.5137.5118.08--
Long-Term Leases
3.733.737.210.310.88-
Long-Term Unearned Revenue
103.07105.02106.92.12--
Long-Term Deferred Tax Liabilities
20.2320.2920.540.9--
Total Liabilities
666.65659.67781.52250.59145.4562.79
Common Stock
808080808080
Additional Paid-In Capital
547.3506.89506.94509.22509.5520.5
Retained Earnings
-6.497.47109.64182.17163.32192.42
Treasury Stock
-4.91-20.99-20.99---
Comprehensive Income & Other
1.141.141.140.68-1.3-
Total Common Equity
617.03574.51676.73772.06751.53792.92
Minority Interest
43.9849.0376.7449.611.89-4.28
Shareholders' Equity
661.01623.54753.47821.68753.41788.63
Total Liabilities & Equity
1,3281,2831,5351,072898.87851.42
Total Debt
259.36270.35538.5180.12101.2420.48
Net Cash (Debt)
-193.91-165.03-134.69302.72404.53590.45
Net Cash Growth
----25.17%-31.49%750.31%
Net Cash Per Share
-2.45-2.08-1.703.855.139.05
Filing Date Shares Outstanding
77.679.1478.96808080
Total Common Shares Outstanding
77.679.1478.96808080
Working Capital
-121.58-113.07121.38519.77502.85666.26
Book Value Per Share
7.957.268.579.659.399.91
Tangible Book Value
523.81479.17579.04734.19730.29776.06
Tangible Book Value Per Share
6.756.057.339.189.139.70
Buildings
--506.96167.55117.46103.71
Machinery
--251.45126.263.4760.37
Construction In Progress
--5.679.083.940.36
Source: S&P Global Market Intelligence. Standard template. Financial Sources.